Yvoire Volume Plus Regulatory Status: Essential Insights for Professionals

Yvoire Volume Plus is a hyaluronic acid dermal filler manufactured by LG Chem, a major South Korean life sciences company. Designed for professional use, this product is intended for volume restoration and contouring procedures. Its formulation and presentation are developed to meet the standards required by aesthetic practitioners globally.

As part of a comprehensive range of aesthetic injectables, Yvoire Volume Plus represents one option available within the broader Hyaluronic acid dermal filler catalog for professional inventory needs.

LG Chem, as the manufacturer of Yvoire Volume Plus, operates under stringent quality control protocols. The product holds KFDA approval in South Korea, signifying its compliance with the regulatory standards of its country of origin. Additionally, Yvoire Volume Plus typically holds a CE mark for distribution within the European Economic Area. [VERIFY: Specific CE certification details and Notified Body for Yvoire Volume Plus].

Beyond product-specific approvals, LG Chem's manufacturing facilities adhere to ISO standards and Good Manufacturing Practices (GMP), foundational requirements for medical device production. While these certifications support international market access, Yvoire Volume Plus is generally not directly FDA-approved for commercial distribution in the United States. [VERIFY: Current FDA approval status for Yvoire Volume Plus for direct US market sale].

For market access within the European Union, a valid CE mark is a prerequisite for Yvoire Volume Plus. This certification confirms the product's conformity with EU health, safety, and environmental protection standards. Post-Brexit, the UK continues to recognize CE marking for medical devices for a transitional period, though specific UKCA mark requirements may evolve.

Professionals sourcing for EU and UK clinics must ensure their supplier can provide clear documentation of the product’s CE status and confirm its legal distribution channels within their specific region.

Market access for Yvoire Volume Plus in the GCC (Gulf Cooperation Council) and LATAM (Latin America) regions is dictated by individual national health authority registrations. Countries like Saudi Arabia (SFDA), UAE (MoHAP), Brazil (ANVISA), and Mexico (COFEPRIS) each have distinct processes requiring local registration, often demanding certificates of origin, GMP compliance, and free sale certificates.

Understanding these varied requirements is essential for compliant sourcing. For insights into other product regulatory landscapes in these regions, consider reviewing resources such as Metoo Fill+ Regulatory Status: Essential Insights for Profes.

The Asia-Pacific region presents a diverse regulatory environment for aesthetic injectables like Yvoire Volume Plus. While KFDA approval ensures compliance in South Korea, other countries such as Australia, Singapore, and Thailand have their own regulatory bodies (TGA, HSA, TFDA, respectively) with specific registration and import requirements.

Due to the varied regulatory frameworks, professionals in APAC must conduct due diligence to ensure that their sourced products, including options such as Elasty Plus 1CC, are legally registered and compliant in their specific market.

Parallel imports of aesthetic injectables, including Yvoire Volume Plus, refer to products legally placed on the market in one country and then imported into another without the express consent of the manufacturer's official distributor network. While often presenting a different price point, professionals must verify the legality of such imports within their specific jurisdiction.

Sourcing through parallel channels necessitates heightened diligence to confirm product authenticity, proper handling, and adherence to all local import regulations. A deeper understanding of such sourcing considerations can be found in guides like Dermalax Deep Plus Wholesale: A Professional Sourcing Guide.

Regardless of market or supplier, authenticating Yvoire Volume Plus is paramount. Professionals should demand clear documentation from their suppliers, including traceable lot numbers, manufacturing and expiry dates, and a Certificate of Authenticity that links directly to LG Chem.

Suppliers should also provide evidence of appropriate cold chain management during shipping to maintain product integrity. This diligence is crucial for ensuring product quality and patient safety for all aesthetic injectables, including products such as Hyaldew, sourced for clinic inventory.